Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 8, 2010, Pages 1218-1223

  Fernandes, M T B ^a   Ferraro, A A ^b   De Azevedo, R A ^a   Fagundes Neto, U ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Developmental stage; Gender; Non alcoholic fatty liver disease; Paediatrics

Indexed keywords

AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC CAPACITY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; ULTRASOUND;

ADOLESCENT; ANTHROPOMETRY; BODY COMPOSITION; BRAZIL; CHILD; CHOLESTEROL; FATTY LIVER; FEMALE; HUMANS; MALE; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 77954353798     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01774.x     Document Type: Article

References (30)

1. Schwimmer JB. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Semin Liver Dis 2007 27 : 312 318.
2. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003 143 : 500 505.
3. Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006 291 : 697 703.
4. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 2006 43 : 413 427.
5. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995 127 : 700 704.
6. Tominaga K, Kurata JH, Chen YK, Fugimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995 40 : 2002 2009.
7. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005 115 : 561 565.
8. Kahen T, Schwimmer JB, Lavine JE, Deutsch R, Stanley C, Behling C. Population prevalence of pediatric fatty liver disease. Gastroenterology 2004 126 : A753 4.
9. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000 24 : 772 776.
10. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 2001 50 : 2444 2450.
11. Cook JS, Hoffman RP, Stene MA, Hansen JR. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 1993 77 : 725 730.
12. Tanner JM. Worldwide variation in human growth.
13. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from National high Blood Pressure Education Program. Pediatrics 1996 98 : 649 658.
14. American Academy of Pediatrics, Committee on Nutrition. Cholesterol in childhood. Pediatrics 1998 101 : 141 147.
15. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005 28 : S4 36.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419.
17. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index (QUICKI) for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002 87 : 144 147.
18. Armellini F, Zamboni M, Rigo L, Bergamo-Andreis IA, Robbi R, Marchi M. Sonography detection of small intra-abdominal fat variations. Int J Obes 1991 15 : 847 852.
19. Ribeiro Filho FSF. Identificação de indivíduos obesos de alto risco cardiovascular através da mensuração ultra-sonográfica da adiposidade visceral (tese). Universidade Federal de São Paulo
20. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006 118 : 1388 1393.
21. Fishbein MH, Cox S. Non-alcoholic fatty liver in a toddler. Clin Pediatr (Phila) 2004 43 : 483 485.
22. Kimata H. Increased incidence of fatty liver in non-obese Japanese children under 1 year of age with or without atopic dermatitis. Public Health 2006 120 : 176 178.
23. Chan DFY, Li AM, Chu WCW, Chan MHM, Wong EMC, Liu EKH, et al. Hepatic steatosis in obese Chinese children. Int J Obes 2004 28 : 1257 1263.
24. Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum γ-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J Clin Endocrinol Metab 2006 91 : 1419 1422.
25. Manco M, Marcellini M, DeVito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes 2008 32 : 381 387.
26. Schwimmer JB, Behling C, Newbury R, Deutsh R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005 42 : 641 649.
27. Schwimmer JB, Khorram O, Chiu V, Schwimmer WB. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 2005 83 : 494 497.
28. Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007 47 : 412 417. (Pubitemid 47176161)
29. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004 89 : 61 70.
30. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008 28 : 386 395.